The National Institute of Neurological Disorders and Stroke (NINDS) encourages small business innovation research (SBIR) and small business technology transfer (STTR) applications for NINDS cooperative small business awards in translational research.*
The NINDS translational research program supports the preclinical development of treatments for neurological disorders. The program uses a number of grant and cooperative agreement mechanisms to fund both exploratory/developmental work and milestone-driven therapy development programs.
Areas of research interest include, but are not limited to: identification of targets for therapeutic intervention; development of assays that permit the preliminary screening of candidate therapeutics; development of animal models that permit further evaluation of candidate therapeutics and/or toxicology studies; development of tools and technologies that can be directly used for therapy development; preliminary identification of candidate therapeutics that can be evaluated through further preclinical testing; and testing of therapeutics for efficacy in cell-based or animal models of a neurological disorder.
For more information, potential applicants should contact Dr. Thomas Miller, Program Direct or, Technology Development Group, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2139, Bethesda, MD 20892; telephone: 301-496-1779; fax: 301-402-1501; e-mail: email@example.com.
*For a more detailed description of this program announcement, please visit the NIH web site at: http://grants.nih.gov/grants/guide/pa-files/PAR-05-159.html.